Down-regulation of EGFR protein either by siRNA or by a synthetic EGFR-down regulating peptide (Herdegradin) can kill prostate and ovarian cancer cells via selective mitophagy by activating the mTORC2/Akt axis (26). The gene discussed is AKT1; the disease is ovarian carcinoma.